Navigation Links
Citalopram, a Boon in Treating Depressed Heart Patients

Canadian researchers have come out with findings from a study that indicates the superiority of selective serotonin reuptake inhibitors (SSRIs) like celexa in combating// depression.

Dr. Fran?ois Lespérance, a psychiatrist at the University of Montreal and his colleagues published their findings in this week’s edition of the Journal of the American Medical Association.

The drug celexa, which goes by the generic name citalopram, is prescribed for patients suffering from major depression that lasts more than two weeks.

Depression is commonly associated with coronary heart disease or CAD. Around 17 to 27 percent of CAD diagnosed patients are found to suffer from depression.

The study involved 284 CAD patients and lasted a period of 12 weeks.

They were asked to undergo three modes of treatment: half to take clinical management with or without psychotherapy sessions and the other half to take the drug celexa or a placebo.

Clinical management included doctor visits to discuss depression and medication use, provide reassurance, and inquire about patients' symptoms. Psychotherapy took place immediately after the clinical management sessions, and dealt with problems such as interpersonal conflicts, life transitions, grief and loss, and social isolation.

The results observed showed that there was reduction in depression symptoms by half as compared with that of the control patients, while surprisingly psychotherapy sessions did not show any reduction in depression.

Standardized depression scores were 67 percent more likely to drop by half on citalopram than placebo, and the chance of depression remitting was almost doubled.

Says Dr. Lesperance, "Citalopram or sertraline, as previously shown in [a different trial], plus clinical management should be considered for the initial acute-phase treatment for major depression in patients with coronary artery disease.”

Physicians Alexan der Glassman and J. Thomas Bigger of the New York State Psychiatric Institute who opine that the study provides further evidence that SSRIs combat depression in heart disease victims support the authors’ findings.
NN
'"/>




Related medicine news :

1. Treating eye pain eases migraine
2. Treating wounds without stitches
3. Treating varicose veins
4. Treating acne with laser
5. Once-Daily Cipro(R) XR for Treating Complicated Urinary Tract Infections
6. Treating Stroke Patients in Rural Areas
7. Free Tissue Transfer Effective in Treating Massive Skin Cancers
8. Treating Blocked Arteries In The Lower Limbs
9. Zinc Supplements Found To Be Effective In Treating Children With ADHD
10. Hormone Leptin Found To Be Effective In Treating Women With Infertility Problems
11. Treating Depression In Children Could Lead To Poor Bone Development
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/20/2017)... ... ... As a leading dental practice, Wall Centre Dental supports Stroke Awareness Month ... bleeding gums in Vancouver, BC, may be developing gingivitis, the first stage of ... and diabetes. Drs. Parviz Roshan, Siamak Tehrani and Milton Reskovich offer laser gum therapy ...
(Date:6/20/2017)... ... June 20, 2017 , ... This year, participants in the ... finding product improvements that could reduce the occurrence of unplanned extubations (UEs). ... breathing or to provide medication. Sometimes, patient movement can cause unplanned extubations which ...
(Date:6/20/2017)... ... June 20, 2017 , ... Uniform Advantage ... featuring seven new products designed to create tailored looks and athleisure-inspired outfits. UA Flex ... cotton easy care stretch twill. , With trendy looks hitting the medical community, UA ...
(Date:6/20/2017)... ... , ... John D'Eri, CEO of Rising Tide Car Wash , will ... during the Autism Society of America 's 49th annual conference to be held ... (DJFF) was founded in 2002 as the nation's first autism organization focused exclusively ...
(Date:6/20/2017)... ... June 20, 2017 , ... International water ... The Sharon Kleyne Hour Power of Water, Global Climate Change and Your Health ... world’s water crisis and how it affects the human eyes. , According ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. ... focused on the design, manufacture, sale and distribution of ... on the progress of its commercial roll-out in ... available in more than one hundred (100) medical institutions ... AeroForm offers a needle-free alternative for women who ...
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
Breaking Medicine Technology: